Cardicare E Gyan Te May 19

Arbitel has completed 10 years of quality and efficacy.

The correct answer is Telmisartan 40 mg+ Amlodipine 5 mg. This is because the composition of Arbitel AM 40 is a combination of Telmisartan and Amlodipine, with Telmisartan being present in a dosage of 40 mg and Amlodipine in a dosage of 5 mg. None of the other options provided match this specific combination of dosages.

Arbitel AV is recommended in Lipitension.

Arbitel MT is recommended in high-risk hypertensive patients. This medication is specifically designed to manage hypertension in patients who are at a high risk of cardiovascular events. It combines two active ingredients, which are effective in lowering blood pressure and reducing the risk of complications associated with hypertension. Therefore, Arbitel MT is the appropriate choice for high-risk hypertensive patients.

Arbitel CT is a medication that is used to treat uncontrolled hypertension. It works by reducing both systolic blood pressure (SBP) and diastolic blood pressure (DBP) levels. Therefore, it can be concluded that the statement "Arbitel CT reduces SBP and DBP in uncontrolled Hypertension" is true.

Arbitel CT is indicated in uncontrolled hypertension because it is a medication used to treat high blood pressure that is not adequately controlled with other medications or lifestyle changes. It helps to lower blood pressure and reduce the risk of complications associated with hypertension.

Arbitel is classified as a Cardio metabolic Sartan. This means that it is a type of medication that is used to treat cardiovascular and metabolic conditions. Sartans are a class of drugs that are commonly used to treat high blood pressure and heart failure. Therefore, the statement that Arbitel is a Cardio metabolic Sartan is true.

Arbitel is indicated in all of the above conditions, which include essential hypertension, diabetic hypertension, and uncontrolled hypertension. This means that Arbitel can be used to treat and manage these types of hypertension.

not-available-via-ai

The statement "Arbitel has short half life" is false. The term "half-life" refers to the time it takes for half of a substance to decay or be eliminated from the body. Arbitel is a medication used to treat high blood pressure and heart failure. It has a long half-life, which means it remains in the body for a longer duration. This allows for a sustained effect and less frequent dosing compared to medications with shorter half-lives. Therefore, the correct answer is false.

The statement suggests that in order to earn call average, compliance, and RCPA Norms incentives, as well as to adhere to the reporting schedule set by the company, it is necessary to have positive growth. Therefore, disbursement will only occur on a quarterly basis if there is no negative growth.

Dabilong is effective in secondary prevention of stroke. This means that Dabilong has been proven to be successful in preventing a second stroke from occurring in individuals who have already had a stroke in the past. This could be through various mechanisms such as reducing blood clot formation, improving blood flow, or controlling risk factors for stroke. Therefore, the statement is true.

The statement suggests that Astin, a medication or treatment, has been found to effectively reduce plaque buildup in patients with coronary disease. This implies that Astin is beneficial in managing this condition and can potentially improve the health of individuals with coronary disease. Therefore, the answer is true.

Telmisartan is a medication used to treat high blood pressure. It belongs to a class of drugs called angiotensin receptor blockers (ARBs) which work by relaxing blood vessels. Arterial stiffness refers to the loss of elasticity in the arteries, which can lead to increased cardiovascular risk. Studies have shown that telmisartan can improve arterial stiffness, resulting in a beneficial reduction. Therefore, the statement that telmisartan shows a beneficial reduction in arterial stiffness is true.

The correct answer is Rs. 500 - Achieve 70% of your sales by 21st of the month. This option offers the highest amount of money for achieving the same sales target of 70% by the 21st of the month. The other options either have a lower payout or a later deadline, making them less favorable choices.

Based on the given information, if the PCPM (Per Capita Per Month) is 2.5 Lac (Lakh) and the growth is greater than or equal to 30%, TE (Total Earnings) will earn an incentive of 8400.

Dabilong has a rapid onset of action within 1-2 hours. This means that after taking Dabilong, its effects will start to be noticeable within this time frame.

The given answer, (CYS-LYS/LYS)*100, is the correct calculation for growth. It involves subtracting the initial value (CYS) from the final value (LYS), dividing it by the initial value (LYS), and then multiplying by 100 to express it as a percentage. This formula allows us to determine the percentage increase or decrease in growth over a given period.

If the TE sale is 24 Lac in one year, the TE will be eligible to receive an annual incentive of 30 K Utility Item.

Based on the given information, if the PCPM (per capita per month) is 1.5 Lac (150,000) and the growth is greater than or equal to 35%, TE (presumably referring to a specific person or group) will receive an incentive of 3150. This suggests that the incentive amount is calculated based on the PCPM and the growth rate, resulting in a specific amount of 3150.

If TE achieves 1.3 Cr annually with a 25% growth, they will receive an incentive of 3 lac. This means that if their annual revenue increases by 25% and reaches 1.3 Cr, they will be rewarded with a cash incentive of 3 lac.

not-available-via-ai

The correct answer is Rs. 500 - Minimum for core and targeted doctors. This means that the minimum amount required for core and targeted doctors is Rs. 500. It does not include chemists, stockists, or c&f.

Product wise incentives are released annually. This means that the incentives for each product are given out once a year. This could be done to align with the company's budgeting and financial planning processes, as well as to allow for a comprehensive evaluation of the product's performance over a longer period of time. Releasing incentives annually also provides motivation for the sales team to consistently perform well throughout the year, knowing that their efforts will be rewarded at the end of the year.

The correct answer is Rs. 500 - Meet minimum 90% of expected 300 doctor calls in the month. This option offers the lowest cost while still meeting a high percentage of the expected doctor calls. It ensures that at least 270 doctor calls are made in a month, which is 90% of the expected 300 calls. This option strikes a balance between cost-effectiveness and meeting the minimum requirement.

The correct answer is Rs. 500 - Minimum 90% visit compliance of all core doctors (2/3 visits) as defined by division. This option offers a lower incentive compared to the other options, indicating that it is the minimum requirement for visit compliance. The requirement of 90% visit compliance means that at least 90% of the core doctors must complete 2 out of 3 visits as defined by the division.

If TE achieves a sale of 48 lac with a 30% growth and hits the target for 2019-20 with a base sale of 37 lac in 2018-19, then TE can earn a total incentive of 4.65 Lac. This can be calculated by taking the base sale of 37 lac and adding the growth percentage of 30% to get the target sale for 2019-20, which is 48 lac. The incentive amount is then calculated by subtracting the base sale from the target sale and multiplying it by the incentive rate. In this case, the incentive rate is 10% (0.10) and the calculation would be (48 lac - 37 lac) * 0.10 = 1.1 lac. Adding this incentive amount to the base sale gives a total incentive of 4.65 Lac.

Based on the given information, the PCPM (Per Capita Per Month) is 9 Lac and the growth is greater than or equal to 12.5. The incentive amount for TE is calculated based on these factors. Since the growth is sufficient and meets the criteria, the incentive amount will be the highest value among the options provided, which is 49500.

The correct answer is 13702 because the total earning of incentive is calculated by multiplying the TE PCPM (3.80 lac) by the growth percentage (25%). 3.80 lac multiplied by 25% equals 0.95 lac. Adding this incentive amount to the TE PCPM gives a total earning of 4.75 lac. Converting this amount to rupees gives 475000, which is equal to 13702 in the given options.

Based on the given information, if the PCPM (Per Case Profit Margin) is 4.75 and the growth rate is greater than 30%, the incentive TE (Total Earnings) will be 20900. The exact calculation method is not provided in the question, but it can be inferred that the incentive TE is determined based on the PCPM and the growth rate, resulting in a total earnings of 20900.